An antibody-avidin fusion protein specific for the transferrin receptor serves as a delivery vehicle for effective brain targeting: Initial applications in anti-HIV antisense drug delivery to the brain

Journal of Immunology

Volumn 163, Issue 8, 1999, Pages 4421-4426

  Penichet, Manuel L ^a   Kang, Young Sook ^b   Pardridge, William M ^a   Morrison, Sherie L ^a   Shin, Seung Uon ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sookmyung Women's University   (South Korea)

^c Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AVIDIN; DRUG VEHICLE; HYBRID PROTEIN; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG UPTAKE; HUNTINGTON CHOREA; INFECTION; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TRANSPORT; RAT; RECEPTOR BINDING;

ANIMALS; ANTI-HIV AGENTS; ANTIBODY SPECIFICITY; AVIDIN; BIOTIN; BRAIN; GENE TARGETING; HUMANS; IMMUNOGLOBULIN CONSTANT REGIONS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IODINE RADIOISOTOPES; MALE; MICE; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDE NUCLEIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFERRIN; RECOMBINANT FUSION PROTEINS; TRITIUM;

EID: 0032825682     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Crone, C., and S. P. Olesen. 1982. Electrical resistance of brain microvascular endothelium. Brain Res. 241:49.
2. Butt, A. M., H. C. Jones, and N. J. Abbott. 1990. Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J. Physiol. 429: 47.
3. Pardridge, W. M. 1991. Peptide Drug Delivery to the Brain. W. M. Pardridge, ed. Raven Press, New York. p. 123.
4. Brightman, M. W., and J. H. Tao-Cheng. 1993. Tight junctions of brain endothelium and epithelium. In The Blood-Brain Barrier: Cellular and Molecular Biology. W. M. Pardridge, ed. Raven Press, New York, p. 107.
5. Abbott, N. J., and I. A. Romero. 1996. Transporting therapeutics across the blood-brain barrier. Mol. Med. Today. 2:106.
6. Shapiro, W. R., and J. R. Shapiro. 1986. Principles of brain tumor chemotherapy. Semin. Oncol. 13:56.
7. Olson, L., E. O. Backlund, T. Ebendal, R. Freedman, B. Hamberger, P. Hansson, B. Hoffer, U. Lindblom, B. Meyerson, I. Strömberg, et al. 1991. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease: one-year follow-up of first clinical trial. Arch. Neurol. 48:373.
8. Olson, L., A. Nordberg, H. Vonholst, L. Backman, T. Ebendal, I. Alafuzoff, K. Amberla, P. Hartvig, A. Herlitz, A. Lilja, et al. 1992. Nerve growth factor affects C-11-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient: case report. J. Neural Transm. Park. Dis. Dement. Sect. 4:79.
9. Gash, D. M., Z. Zhang, and G. Gerhardt. 1998. Neuroprotective and neurorestorative properties of GDNF. Ann. Neurol. 44:S121.
10. Duffy, K. R., and W. M. Pardridge. 1987. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res. 420:32.
11. Fishman, J. B., J. B. Rubin, J. V. Handrahan, J. R. Connor, and R. E. Fine. 1987. Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J. Neurosci. Res. 18:299.
12. Reinhardt, R. R., and C. A. Bondy. 1994. Insulin-like growth factors cross the blood-brain barrier. Endocrinology 135:1753.
13. Shin, S. U., P. Friden, M. Moran, and S. L. Morrison. 1994. Functional properties of antibody insulin-like growth factor fusion proteins. J. Biol. Chem. 269:4979.
14. Shin, S. U., P. Friden, M. Moran, T. Olson, Y. S. Kang, W. M. Pardridge, and S. L. Morrison. 1995. Transferrin-antibody fusion proteins are effective in brain targeting. Proc. Natl. Acad. Sci. USA 92:2820.
15. Friden, P. M., L. R. Walus, G. F. Musso, M. A. Taylor, B. Malfroy, and R. M. Starzyk. 1991. Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc. Natl Acad. Sci. USA 88:4771.
16. Friden, P. M., L. R. Walus, P. Watson, S. R. Doctrow, J. W. Kozarich, C. Bäckman, H. Bergman, B. Hoffer, F. Bloom, and A. C. Granholm. 1993. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259:373.
17. Walus, L. R., W. M. Pardridge, R. M. Starzyk, and P. M. Friden. 1996. Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier after conjugation to anti-transferrin receptor antibodies. J. Pharmacol. Exp. Ther. 277:1067.
18. Bullard, D. E., M. Bourdon, and D. D. Bigner. 1984. Comparison of various methods for delivering radiolabeled monoclonal antibody to normal rat brain. J. Neurosurg. 61:901.
19. Kordower, J. H., V. Charles, R. Bayer, R. T. Bartus, S. Putney, L. R. Walus, and P. M. Friden. 1994. Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease. Proc. Natl. Acad. Sci. USA 91:9077.
20. Granholm, A. C., D. Albeck, C. Bäckman, M. Curtis, T. Ebendal, P. Friden, M. Henry, B. Hoffer, J. Kordower, G. M. Rose, S. Söderström, and R. T. Bartus. 1998. A noninvasive system for delivering neural growth factors across the blood-brain barrier: a review. Rev. Neurosci. 9:31.
21. McGrath, J. P., X. Cao, A. Schutz, P. Lynch, T. Ebendal, M. J. Coloma, S. L. Morrison, and S. D. Putney. 1997. Bifunctional fusion between nerve growth factor and a transferrin receptor antibody. J. Neurosci. Res. 47:123.
22. Yoshikawa, T., and W. M. Pardridge. 1992. Biolin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor. J. Pharmacol. Exp. Ther. 263:897.
23. Pardridge, W. M., R. J. Boado, and Y. S. Kang. 1995. Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo. Proc. Natl. Acad. Sci. USA 92:5592.
24. Shin, S. U., D. Wu, R. Ramanathan, W. M. Pardridge, and S. L. Morrison. 1997. Functional and pharmacokinetic properties of antibody-avidin fusion proteins. J. Immunol. 158:4797.
25. Jefferies, W. A., M. R. Brandon, A. F. Williams, and S. V. Hunt. 1985. Analysis of lymphopoietic stem cells with a monoclonal antibody to the rat transferrin receptor. Immunology 54:333.
26. Shin, S. U., and S. L. Morrison. 1989. Production and properties of chimeric antibody molecules. Methods Enzymol. 178:459.
27. Pardridge, W. M., Y. S. Kang, and J. L. Buciak. 1994. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm. Res. 11:738.
28. Wu, D., Y. S. Kang, U. Bickel, and W. M. Pardridge. 1997. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab. Dispos. 25:768.
29. Kang, Y. S., U. Bickel, and W. M. Pardridge. 1994. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor. Drug Metab. Dispos. 22:99.
30. Capon, D. J., S. M. Chamow, J. Mordenti, S. A. Marsters, T. Gregory, H. Mitsuya, R. A. Byrn, C. Lucas, F. M. Wurm, J. E. Groopman, et al. 1989. Designing CD4 immunoadhesins for AIDS therapy. Nature 337:525.
31. Pollio, G., P. Xue, M. Zanisi, A. Nicolin, and A. Maggi. 1993. Antisense oligonucleotide blocks progesterone-induced lordosis behavior in ovariectomized rats. Brain Res. Mol. Brain Res. 19:135.
32. Wahlestedt, C., E. M. Pich, G. F. Koob, F. Yee, and M. Heilig. 1993. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259:528.
33. Boado, R. J. 1995. Antisense drug delivery through the blood-brain barrier. Adv. Drug Delivery Rev. 15:73.
34. Pardridge, W. M., D. Wu, and T. Sakane. 1998. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration. Pharm. Res. 15:576.
35. Wu, D., and W. M. Pardridge. 1999. Neuroprotection with noninvasive neurotrophin delivery to the brain. Proc. Natl. Acad. Sci. USA 96:254.